Complete

Starving cancer to stop metastasis

Cancer types:

Oral cancer

Project period:

Research institute:

Deutsches Krebsforschungszentrum

Award amount:

£244,500

Location:

Germany

Researcher Dr Michaela Frye

Dr Michaela Frye and her team are investigating a way to cut off cancer’s energy supply to prevent or treat cancer metastasis.

Hope for the future

Oral squamous cell carcinoma – the most common form of mouth cancer – has a high tendency to spread or metastasise and less than half of people diagnosed survive for 10 years or more. By studying how cancer cells get the energy they need to grow and spread, Dr Frye hopes to find ways to prevent or treat metastasis and improve survival rates. 

Meet the scientist

Besides science, Dr Michaela Frye enjoys watching stand-up comedy and going to the theatre. She relaxes by going out for a nice dinner and reading one of her favourite authors - Paul Auster. 

The science

Metastasis remains one of the main reasons for cancer deaths. Once cancer has spread, only a very small number of patients can be successfully treated with conventional treatments such as surgery, chemotherapy or radiotherapy. There are still many unknowns about how metastasis works, but we know that to successfully colonise other organs, tumour cells must adapt to drastically different environments. The new environment that the tumour cells encounter once they break away from the original tumour, can have different levels of oxygen, energy sources and nutrients available. 

This extreme flexibility that tumour cells need during metastasis is largely provided by mitochondria – the “powerhouses” of the cell. Dr Frye and her team are now testing whether stopping mitochondria from providing the required energy to the tumour cells could open new ways to prevent or treat cancer metastasis. 

Over the last 15 years my group has studied a group of enzymes that modify RNA molecules. However, evidence that they are important in cancer has only emerged in the last 4 years. My hope is that they are exploited for new therapies within the next 5 years. 

Dr Michaela Frye

Related projects

Lesley Stark Headshot

Active United Kingdom

Bowel cancer

Journey to the centre of a cell: why does age matter in cancer?

With your support, Professor Lesley Stark and her team in Edinburgh hope to find new ways to prevent cancer linked to ageing. This has huge potential to reveal new approaches to cancer treatment or to prevent it developing in older people. 

Researcher: Professor Lesley Stark

Journey to the centre of a cell: why does age matter in cancer?
Ruud Delwel Headshot

Active Netherlands

Leukaemia

Mission impossible: how can we target “Evi1” leukaemias?

Thanks to our Curestarters, Professor Delwel and his team in the Netherlands hope to find a much-needed new leukaemia cure. Acute Myeloid Leukaemia (AML) can sometimes be caused by a specific gene, so by better understanding this gene we can look for new cures. 

 

Researcher: Professor Ruud Delwel

Mission impossible: how can we target “Evi1” leukaemias?
Jurian Schuijers Headshot

Active Netherlands

Bowel cancer

Could targeting tiny droplets inside cells help to treat bowel cancer?

Dr Schuijers and his team in the Netherlands are using Curestarter funding to look for new bowel cancer cures. The team think that disrupting certain 'droplets' could be a powerful new way to stop cancer. 

Researcher: Dr Jurian Schuijers

Could targeting tiny droplets inside cells help to treat bowel cancer?
Share this page